SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-21-000094
Filing Date
2021-03-24
Accepted
2021-03-24 08:01:59
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMNEAL PHARMACEUTICALS, INC. - DEFA14A lamrx2021_defa14a.htm DEFA14A 12581
2 GRAPHIC box1.jpg GRAPHIC 1082
3 GRAPHIC checkbox1.jpg GRAPHIC 1317
4 GRAPHIC lamrx_notice1.jpg GRAPHIC 375806
5 GRAPHIC lamrx_notice2.jpg GRAPHIC 258312
6 GRAPHIC lamrxx1x1.jpg GRAPHIC 10981
  Complete submission text file 0001308179-21-000094.txt   905910
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38485 | Film No.: 21766714
SIC: 2834 Pharmaceutical Preparations